Report on our Phase II trial for a HER2 breast cancer vaccine in combination with immune checkpoint inhibition

Jun 26, 2022 - Report on our Phase II trial for a HER2 breast cancer vaccine in combination with immune checkpoint inhibition

| News Observer | Eureka Alert